About CorisBio
CorisBio is a company based in Gembloux (Belgium) founded in 1996 was acquired by Avacta in June 2023.. CorisBio offers products and services including BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT. CorisBio operates in a competitive market with competitors including OpGen, Avails Medical, Resistell, NOWDiagnostics and HandyLab, among others.
- Headquarter Gembloux, Belgium
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CorisBio
CorisBio offers a comprehensive portfolio of products and services, including BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects beta lactamases via electrochemistry technology
Identifies OXA-48-like carbapenemases using lateral flow
Tests for KPC, NDM, VIM, IMP carbapenemases
Detects Cryptosporidium and Giardia parasites
Identifies Influenza A and B viruses via lateral flow
Funding Insights of CorisBio
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $575,645
-
First Round
First Round
(01 Jan 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Grant - CorisBio | Valuation |
investors |
|
| Jan, 2015 | Amount | Grant - CorisBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CorisBio
CorisBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Avacta and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Developer of therapeutics and diagnostics for the treatment of cancer
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CorisBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CorisBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corisbio Comparisons
Competitors of CorisBio
CorisBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Avails Medical, Resistell, NOWDiagnostics and HandyLab, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| domain | founded_year | HQ Location |
Antibiotic susceptibility testing is provided via bacterial movement detection.
|
|
| domain | founded_year | HQ Location |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays and automation platforms are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for molecular pathogen detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corisbio
Frequently Asked Questions about CorisBio
When was CorisBio founded?
CorisBio was founded in 1996 and raised its 1st funding round 19 years after it was founded.
Where is CorisBio located?
CorisBio is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
What does CorisBio do?
Coris BioConcept is engaged in the development, production and commercialization of rapid diagnostic tests for the detection of the pathogen for enteric, gastric and respiratory diseases. The company utilizes immunochromatography technology with colloidal gold particles or latex microspheres to develop their products. The tests are available in two formats: dipstick and cassette. The company also offers tests under the brand name RESIST for the detection of antibiotic-resistant bacteria. The company offers products in more than 70 countries in Europe, Asia, South America, Africa, Oceania, Ireland, United Kingdom, and Norway. It is among the leaders on the Belgian market (80).
Who are the top competitors of CorisBio?
CorisBio's top competitors include Avails Medical, OpGen and Verax Biomedical.
What products or services does CorisBio offer?
CorisBio offers BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT.
Who are CorisBio's investors?
CorisBio has 2 investors. Key investors include Avacta, and European Union.